Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients

BACKGROUND: Hyperphosphatemia is associated with increased mortality and cardiovascular morbidity of end-stage kidney failure (ESKF) patients. Managing serum phosphate in ESKF patients is challenging and mostly based on limiting intestinal phosphate absorption with low phosphate diets and phosphate...

Descripción completa

Detalles Bibliográficos
Autores principales: Egli-Spichtig, Daniela, Hamid, Ahmad Kamal, Arroyo, Eva Maria Pastor, Ketteler, Markus, Wiecek, Andrzej, Rosenkranz, Alexander R, Pasch, Andreas, Lorenz, Horst, Hellmann, Burkhard, Karus, Michael, Ammer, Richard, Rubio-Aliaga, Isabel, Wagner, Carsten A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539220/
https://www.ncbi.nlm.nih.gov/pubmed/37779856
http://dx.doi.org/10.1093/ckj/sfad040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539220/
https://www.ncbi.nlm.nih.gov/pubmed/37779856
http://dx.doi.org/10.1093/ckj/sfad040

Ejemplares similares